Solara Active Pharma Sciences Limited (SOLARA) — Financial Flexibility Index
Solara Active Pharma Sciences Limited (SOLARA) has a Financial Flexibility Index of 0.10x as of September 2025. Free cash flow of Rs1.03 Billion (operating CF Rs740.70 Million minus capex Rs286.00 Million) represents 0% of total liabilities (Rs10.36 Billion). Check how strategically is Solara Active Pharma Sciences Limited's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Solara Active Pharma Sciences Limited Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Solara Active Pharma Sciences Limited across 9 annual periods. See Solara Active Pharma Sciences Limited (SOLARA) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Solara Active Pharma Sciences Limited (2017–2025)
Year-by-year free cash flow to debt coverage for Solara Active Pharma Sciences Limited. For the full company profile including market capitalisation, see SOLARA market cap overview.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.22x | Rs2.53 Billion | Rs2.13 Billion | Rs11.35 Billion | ▲ +110.1% |
| 2024 | 0.11x | Rs1.50 Billion | Rs1.09 Billion | Rs14.14 Billion | ▼ -44.7% |
| 2023 | 0.19x | Rs2.68 Billion | Rs1.56 Billion | Rs13.97 Billion | ▲ +913.0% |
| 2022 | -0.02x | Rs-334.10 Million | Rs-2.42 Billion | Rs14.18 Billion | ▼ -107.3% |
| 2021 | 0.32x | Rs3.30 Billion | Rs1.55 Billion | Rs10.21 Billion | ▼ -33.0% |
| 2020 | 0.48x | Rs5.13 Billion | Rs2.44 Billion | Rs10.63 Billion | ▲ +127.1% |
| 2019 | 0.21x | Rs2.12 Billion | Rs1.60 Billion | Rs10.00 Billion | ▲ +166.5% |
| 2018 | 0.08x | Rs839.59 Million | Rs492.23 Million | Rs10.53 Billion | ▼ -100.0% |
| 2017 | 25442.12x | Rs839.59 Million | Rs492.23 Million | Rs33.00K | — |